Important risk minimisation information, on Abstral (fentanyl citrate) sublingual tablet, for patients prescribed Abstral and their carers

Important risk minimisation information, on Abstral (fentanyl citrate) sublingual tablet, for pharmacists

Important risk minimisation information, on Abstral (fentanyl citrate) sublingual tablet, for physicians

Dear Doctor Letter, Amglidia UK product line

Prescriber Guide for Amglidia UK product line

Patient Alert Card

Prescriber Guide

Apixaban Patient Alert Card

Apixaban Prescriber Guide

Apixaban 2.5mg & 5mg Prescribers Guide. This educational material is provided to further minimize the risk of bleeding that is associated with the use of apixaban and to guide healthcare professionals in managing that risk.

Prescriber guide for Apixaban film coated tablets

Patient alert card for Apixaban 2.5mg FCT

Patient Alert card for Apixaban 5mg film coated tablets, pack size 56

The educational guides for prescribers and individuals at risk will help to increase awareness and provide guidance to mitigate the risks of HIV-1 acquisition and the development of resistance, in line with the UK SmPC.

The educational guides for prescribers and individuals at risk will help to increase awareness and provide guidance to mitigate the risks of HIV-1 acquisition and the development of resistance, in line with the UK SmPC.

The checklist is intended to facilitate consultation between the prescriber and individual during Cabotegravir for PrEP injection visits, to ensure a consistent approach to evaluating, counselling and follow up of individuals to mitigate the risks of HIV-1 acquisition and development of resistance.

The reminder card will provide an additional opportunity to reinforce and remind the individuals at risk of the date of their next injection visit and support adherence to their Cabotegravir for PrEP appointment and dosing schedule.

For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]

For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]

This short checklist is designed to help you and your pharmacist discuss Avarante and decide whether it is right for you. It should be completed as accurately as possible so that the pharmacist can give you the most appropriate advice and/or treatment. Please answer all of the questions by ticking the box that applies. The answers are needed to ensure that Avarante can be supplied appropriately, as it may not be suitable for you if you are taking certain medications or have certain medical conditions. The pharmacist will discuss the questions and your answers with you so any notes you make will help with this. If the pharmacist supplies Avarante to you, please read the leaflet carefully.

This Pharmacy Checklist Quick Guide is provided to assist you in your assessment of a patient’s suitability for Avarante.

It is designed to be used in conjunction with the Avarante Checklist. The Avarante Checklist can be provided to the patient to complete before consultation with you or it can be used as part of your consultation with the patient.

After assessing your customer using the Avarante Pharmacist Checklist Quick Guide, complete and supply them with either the Repeat Purchase Card or Referral Card.

After assessing your customer using the Avarante Pharmacist Checklist Quick Guide, complete and supply them with either the Repeat Purchase Card or Referral Card.

This booklet, together with the Checklist and Pharmacist Checklist Quick Guide (which helps with the interpretation of the patient’s answers), has been developed by Viatris to support pharmacists and pharmacy assistants in managing the risks related to

Avarante and enabling its appropriate supply and use.

This document contains key information to help you identify patients to whom you can supply Avarante, and the advice you should give to help them use the product appropriately.